Liquid biopsies in primary and secondary bone cancers
Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer
Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance
Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma - a translational model
Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
Therapeutics to harness the immune microenvironment in multiple myeloma
A patient with relapsed high-grade serous ovarian carcinoma with somatic <i>RAD51C</i> mutations treated with PARPi monotherapy: a case report
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Base excision repair accessory factors in senescence avoidance and resistance to treatments
GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer
Microvesicles: the functional mediators in sorafenib resistance
An overview of resistance to chemotherapy in osteosarcoma and future perspectives
Insight into the molecular mechanisms of gastric cancer stem cell in drug resistance of gastric cancer
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells
A nano-enhanced vaccine for metastatic melanoma immunotherapy
New insights for drug resistance in metastatic castration-resistant prostate cancer